Beneficient Enters into New GP Primary Capital Transaction

Core Viewpoint - Beneficient has successfully closed a 233,333 primary capital commitment for Cork & Vines Fund I, LP, marking its second GP Primary transaction of the fiscal year and third since the program's launch in late 2024 [1][2][3] Group 1: Transaction Details - The Fund received approximately 233,333 in shares of Beneficient's Resettable Convertible Preferred Stock, which can be converted into Class A common stock [2] - This transaction is expected to increase the collateral for Beneficient's ExAlt loan portfolio by approximately $233,333 in alternative asset interests [2] - Beneficient has entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions for the Fund and its limited partners [2] Group 2: Financial Impact - The transaction is anticipated to add approximately$77,777 to the tangible book value attributable to Beneficient's stockholders, contributing to an aggregate of approximately $10.54 million [3] - Beneficient's GP Primary Commitment Program aims to address the potential demand for primary commitments, estimated at up to$330 billion, to support fundraising efforts [4] Group 3: Company Overview - Beneficient is focused on democratizing the global alternative asset investment market by providing solutions for mid-to-high net worth individuals and small-to-midsized institutions [12] - The company's AltAccess platform offers a secure online environment for customers to explore investment opportunities and receive proposals [12]